GB9419048D0 - Treatment of muscular disorders - Google Patents

Treatment of muscular disorders

Info

Publication number: GB9419048D0
Authority: GB; United Kingdom
Prior art keywords: treatment; muscular disorders; muscular; disorders
Prior art date: 1994-09-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

GB9419048A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Relvas Joao C B

Original Assignee

Relvas Joao C B

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-20

Filing date

1994-09-20

Publication date

1994-11-09

1994-09-20 Application filed by Relvas Joao C B filed Critical Relvas Joao C B

1994-09-20 Priority to GB9419048A priority Critical patent/GB9419048D0/en

1994-11-09 Publication of GB9419048D0 publication Critical patent/GB9419048D0/en

1995-09-15 Priority to JP8510668A priority patent/JPH10505756A/en

1995-09-15 Priority to GB9518887A priority patent/GB2293604B/en

1995-09-15 Priority to AU34816/95A priority patent/AU694957B2/en

1995-09-15 Priority to EP95931336A priority patent/EP0783568A1/en

1995-09-15 Priority to PCT/GB1995/002187 priority patent/WO1996009373A1/en

1995-09-15 Priority to CA002198379A priority patent/CA2198379A1/en

Status Pending legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0656—Adult fibroblasts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Biotechnology (AREA)
Cell Biology (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Immunology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Virology (AREA)
Rheumatology (AREA)
Developmental Biology & Embryology (AREA)
Microbiology (AREA)
Dermatology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

GB9419048A 1994-09-20 1994-09-20 Treatment of muscular disorders Pending GB9419048D0 (en)

Priority Applications (7)

Application Number	Priority Date	Filing Date	Title
GB9419048A GB9419048D0 (en)	1994-09-20	1994-09-20	Treatment of muscular disorders
JP8510668A JPH10505756A (en)	1994-09-20	1995-09-15	Fibroblasts for the treatment of muscle disorders
GB9518887A GB2293604B (en)	1994-09-20	1995-09-15	Dermal fibroblast cells containing muscle-specific DNA and the use of dermal fibroblast cells in the treatment of muscular disorders
AU34816/95A AU694957B2 (en)	1994-09-20	1995-09-15	Fibroblasts for the treatment of muscular disorders
EP95931336A EP0783568A1 (en)	1994-09-20	1995-09-15	Fibroblasts for the treatment of muscular disorders
PCT/GB1995/002187 WO1996009373A1 (en)	1994-09-20	1995-09-15	Fibroblasts for the treatment of muscular disorders
CA002198379A CA2198379A1 (en)	1994-09-20	1995-09-15	Fibroblasts for the treatment of muscular disorders

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB9419048A GB9419048D0 (en)	1994-09-20	1994-09-20	Treatment of muscular disorders

Publications (1)

Publication Number	Publication Date
GB9419048D0 true GB9419048D0 (en)	1994-11-09

Family

ID=10761695

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
GB9419048A Pending GB9419048D0 (en)	1994-09-20	1994-09-20	Treatment of muscular disorders
GB9518887A Expired - Fee Related GB2293604B (en)	1994-09-20	1995-09-15	Dermal fibroblast cells containing muscle-specific DNA and the use of dermal fibroblast cells in the treatment of muscular disorders

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
GB9518887A Expired - Fee Related GB2293604B (en)	1994-09-20	1995-09-15	Dermal fibroblast cells containing muscle-specific DNA and the use of dermal fibroblast cells in the treatment of muscular disorders

Country Status (6)

Country	Link
EP (1)	EP0783568A1 (en)
JP (1)	JPH10505756A (en)
AU (1)	AU694957B2 (en)
CA (1)	CA2198379A1 (en)
GB (2)	GB9419048D0 (en)
WO (1)	WO1996009373A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9715085D0 (en) *	1997-07-18	1997-09-24	Jahoda Amanda J	Gene therapy vehicle
IT1296439B1 (en) *	1997-11-14	1999-06-25	San Raffaele Centro Fond	GENETICALLY MODIFIED MYOGENIC PRECURSORS AND THEIR USE IN GENE AND CELL THERAPY
IT1299201B1 (en) *	1998-05-08	2000-02-29	San Raffaele Centro Fond	GENETICALLY MODIFIED FIBROBLASTS AND THEIR USE
AU2016274797B2 (en)	2015-06-11	2018-09-27	The Board Of Trustees Of The University Of Illinios	Muscular Dystrophy Chimeric Cells and method for treating muscular dystrophies
EP3564362A4 (en)	2016-12-28	2020-07-08	Kyoto Prefectural Public University Corporation	SKELETAL MUSCLE CELLS AND METHOD FOR INDUCING THEREOF
CA3142248A1 (en) *	2019-05-31	2020-12-03	Figene, Llc	Fibroblast therapy for treatment of duchenne muscular dystrophy
US20230340416A1 (en) *	2020-07-14	2023-10-26	Figene, Llc	Augmentation of fibroblast therapeutic activity by complement blockade and/or inhibition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5219740A (en) *	1987-02-13	1993-06-15	Fred Hutchinson Cancer Research Center	Retroviral gene transfer into diploid fibroblasts for gene therapy
WO1989002468A1 (en) *	1987-09-11	1989-03-23	Whitehead Institute For Biomedical Research	Transduced fibroblasts and uses therefor
EP0457856A4 (en) *	1989-06-13	1992-10-21	The Board Of Directors Of The Leland Stanford Junior University	Isolation growth and differentiation of human muscle cells
US5538722A (en) *	1989-06-13	1996-07-23	Stanford University	Isolation, growth, differentiation and genetic engineering of human muscle cells
AU7312891A (en) *	1990-02-12	1991-09-03	Board Of Regents, The University Of Texas System	Satellite cell proliferation in adult skeletal muscle
US5298422A (en) *	1991-11-06	1994-03-29	Baylor College Of Medicine	Myogenic vector systems
AU678158B2 (en) *	1992-04-10	1997-05-22	Fox Chase Cancer Center	Transcription control element for increasing gene expression in myoblasts
WO1993024151A1 (en) *	1992-05-29	1993-12-09	The General Hospital Corporation	Arterial introduction of myoblasts

1994
- 1994-09-20 GB GB9419048A patent/GB9419048D0/en active Pending
1995
- 1995-09-15 GB GB9518887A patent/GB2293604B/en not_active Expired - Fee Related
- 1995-09-15 AU AU34816/95A patent/AU694957B2/en not_active Ceased
- 1995-09-15 CA CA002198379A patent/CA2198379A1/en not_active Abandoned
- 1995-09-15 WO PCT/GB1995/002187 patent/WO1996009373A1/en not_active Application Discontinuation
- 1995-09-15 EP EP95931336A patent/EP0783568A1/en not_active Ceased
- 1995-09-15 JP JP8510668A patent/JPH10505756A/en active Pending

Also Published As

Publication number	Publication date
JPH10505756A (en)	1998-06-09
WO1996009373A1 (en)	1996-03-28
CA2198379A1 (en)	1996-03-28
GB2293604A (en)	1996-04-03
AU694957B2 (en)	1998-08-06
GB2293604B (en)	1996-09-11
GB9518887D0 (en)	1995-11-15
EP0783568A1 (en)	1997-07-16
AU3481695A (en)	1996-04-09

Publication	Publication Date	Title
AUPM864894A0 (en)	1994-11-03	Treatment of bowel-dependent neurological disorders
PL339425A1 (en)	2000-12-18	Treatment of behavioural disorders
IL123601A0 (en)	1998-10-30	Use of epinastine for the treatment of pain
GB9407135D0 (en)	1994-06-01	Treatment of osteoporosis
GB9401520D0 (en)	1994-03-23	Treatment of poultry
EP1063990A4 (en)	2003-01-02	Therapy of estrogen-associated disorders
IL115664A0 (en)	1996-01-19	Treatment of disorders with duloxetine
EP1030663A4 (en)	2002-06-26	Treatment of fibromyalgia and related disorders
PL332313A1 (en)	1999-08-30	Application of benzopyranoles in treatment of neurological disorders
GB9518887D0 (en)	1995-11-15	Treatment of muscular disorders
GB9303157D0 (en)	1993-03-31	Treatment of a group of related disorders
IL131347A0 (en)	2001-03-19	Treatment of skin disorders
ZA947912B (en)	1995-05-24	Treatment of medical disorders associated with free radical formation
ZA953237B (en)	1995-12-28	Medical treatment
GB9400600D0 (en)	1994-03-09	Treatment of motion seckness
ZA95511B (en)	1996-03-11	Treatment of anorectal disorders
GB9403407D0 (en)	1994-04-13	Muscle treatment
AU5397994A (en)	1994-08-18	Treatment of skin disorders
GB9727001D0 (en)	1998-02-18	Treatment of movement disorders
GB9503955D0 (en)	1995-04-19	Muscle treatment
GB9815188D0 (en)	1998-09-09	Treatment of skin disorders
GB9520494D0 (en)	1995-12-13	Treatment of medical conditions
GB9520496D0 (en)	1995-12-13	Treatment of medical conditions
GB9520495D0 (en)	1995-12-13	Treatment of medical conditions
ZA975269B (en)	1998-08-21	Stimulation of muscles

Legal Events

Date	Code	Title	Description
1995-09-06	730A	Proceeding under section 30 patents act 1977